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Abstract: Purpose: Preoperative pulmonary assessment is undertaken in patients with resectable lung cancer to identify 
those at increased risk of perioperative complications. Guidelines from the American College of Chest Physicians indicate 
that if the FEV1 and DLCO are 60% of predicted, patients are suitable for resection without further evaluation. 
The aim of our study is to determine if quantitative measures of lung volume and density obtained from pre-operative CT 
scans correlate with pulmonary function tests. This may allow us to predict pulmonary function in patients with lung 
cancer and identify patients who would tolerate surgical resection. 
Materials and Methods: Patients were identified retrospectively from the lung cancer database of a tertiary hospital. Image 
segmentation software was utilized to estimate total lung volume, normal lung volume (values -500 HU to -910 HU), 
emphysematous volume (values less than -910 HU), and mean lung density from pre-operative CT studies for each patient 
and these values were compared to contemporaneous pulmonary function tests. 
Results: A total of 77 patients were enrolled. FEV1 was found to correlate significantly with the mean lung density 
(r=.762, p<.001) and the volume of emphysema (r= -.678, p<.001). DLCO correlated significantly with the mean lung 
density (r =.648, p<.001) and the volume of emphysematous lung (r= -.535, p<.001). 
Conclusion: The results of this study suggest that both FEV1 and DLCO correlate significantly with volume of 
emphysema and mean lung density. We now plan to prospectively compare these CT parameters with measures of good 
and poor outcome postoperatively to identify CT measures that may predict surgical outcome preoperatively. 
Keywords: Computed tomography, lung density, pulmonary function. 
INTRODUCTION 
 Lung cancer is one of the leading causes of death from 
cancer worldwide. There was an estimated 222,520 new 
cases of lung cancer in the United States in 2010, with 
157,300 deaths [1]. The 5-year survival rate varies with 
TNM stage, from 77% (stage pIA) to 2% (stage cIV) for 
patients with local and advanced stage disease respectively 
[2]. 
 Surgical resection and radical radiotherapy remain the 
only curative options for patients with localized non-small 
cell lung cancer (NSCLC). However, only 20-25% of 
patients have surgically resectable disease at the time of 
diagnosis. Mortality rates of 5.4% and 3.2% are reported for 
pneumonectomy and lobectomy respectively [3, 4]. 
 Preoperative pulmonary assessment is performed in 
patients with resectable disease to identify those at increased 
risk of perioperative complications and to establish baseline 
pulmonary function prior to exposure to potential 
pneumotoxic chemo- and radiotherapy. 
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 Guidelines from the American College of Chest 
Physicians indicate that the forced expiratory volume in one 
second (FEV1) and the diffusing capacity of carbon 
monoxide (DLCO) should be measured initially. If the FEV1 
and DLCO are 60% of predicted, patients are at low risk of 
complications and can undergo resection without further 
testing. However if the FEV1 or DLCO are <60% predicted, 
further evaluation with a quantitative lung scan or 
cardiopulmonary exercise testing is recommended [5]. 
 The aim of our study is to determine if quantitative 
measures of lung volume and density obtained from pre-
operative CT scans correlate with pulmonary function tests. 
This may allow us to predict pulmonary function in patients 
with lung cancer and identify patients who would tolerate 
surgical resection. 
MATERIALS AND METHODS 
Patients 
 Patients were identified retrospectively from the lung 
cancer database of a tertiary hospital. Inclusion criteria were 
the availability of a CT thorax and pulmonary function tests 
(PFT’s) from May 2009 to April 2010. Exclusion criteria were 
previous pneumonectomy, lobectomy, and pleural effusion. 
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 Patients with radiological evidence of pulmonary fibrosis 
on CT were also excluded. 
 Ethical approval was granted by the Clinical Research 
Ethics Committee of our institution. 
Computed Tomography 
 CT thorax scans were acquired using a 64-slice GE 
Medical Systems Lightspeed Volume CT (GE Healthcare, 
Wisconsin, USA) or a 4-slice Toshiba Aquilion 
multidetector row CT (Toshiba America Medical Systems, 
Tustin, CA, USA). After infusion of intravenous contrast 
media, the chest region was scanned during breath-hold at 
the end of inspiration in the supine position. Automated 
bolus tracking software was used to trigger image acquisiton 
with a threshold of 100 HU in a region of interest placed 
over the thoraic aorta. 
 Lung density and volume measurements were performed 
using the OsiriX digital analysis programme (OsiriX 
Imaging Software, v3.7.1, OsiriX Foundation, Geneva). 
Image segmentation software was used to segment lung 
parenchyma according to predetermined density thresholds. 
Lung attenuation threshold limits of -500 to -1024 HU were 
used to exclude soft tissue surrounding the lungs. Areas with 
attenuation values less than -910 HU were considered 
representative of poorly functioning emphysematous lung. 
 Following this, quantitative measures of volume and 
density of each segment were calculated. The following CT 
parameters were calculated for each patient: total lung 
volume (TLV), the volume of normal lung parenchyma 
(values -500 HU to -910 HU), the volume of emphysematous 
lung (values less than -910 HU), and the mean lung density 
(see Fig. 1). The regions highlighted in green represent lung 
that has an attenuation value of less than -910 HU and is 
considered to represent emphysematous lung. 
Pulmonary Function Testing 
 All pulmonary function tests were performed in a 
dedicated pulmonary function laboratory. Spirometric values 
including forced expiratory volume in 1 second (FEV1), 
forced vital capacity (FVC), FEV1/FVC ratio, the mean mid-
expiratory flow between 75% and 25% of the FVC (MMEF 
75-25), maximum expiratory flow at 50% of forced vital 
capacity [MEF 50], peak expiratory flow at 50% (PEF), and 
forced expiratory time (FET) were measured using a Jaeger 
Masterscreen Pneumo spirometer (Jaegar/HP/Dell; San 
Diago, CA, USA). 
 The diffusion capacity of the lung for carbon monoxide 
[DLCO], and the DLCO corrected for alveolar volume were 
measured with a Jaegar Masterscreen diffusion analyzer 
(Jaegar/HP/Dell; San Diago, CA, USA). All pulmonary 
function data are presented as a percentage of predicted 
values for the patient’s age, gender and height [11].
 
Statistical Analysis 
 Statistical analyses of the data were performed using the 
Statistical Package for the Social Sciences software (SPSS 
version 19.0; SPSS; Chicago, IL, USA). 
 Univariate correlations were examined using Pearson’s 
product-moment correlation coefficient or Spearman’s rank 
correlation in the case of nonnormally distributed data. 
 All tests were two-tailed and a p-value <0.05 was 
considered statistically significant. Data are expressed as 
means ± SD. 
RESULTS 
 92 patients were identified for inclusion in the study. 15 
patients were excluded due to pleural effusion (n=8), CT 
evidence of pulmonary fibrosis (n=4), previous 
pneumonectomy (n=2), or lobectomy (n=1). In total, 77 
patients were included in the study with a mean age of 68 ± 
12 years (range, 30-88 years). 41 patients had a histological 
diagnosis of adenocarcimona, 20 of squamous cell 
carcinoma, and 16 of small cell carcimona. 44 patients in the 
cohort were current smokers with 15 ex-smokers. 54 patients 
(70%) were male. The mean FEV1 (% of predicted) was 
88.1±24.3 and the mean DLCO (% of predicted) was 56.5 ± 
21.5. 
 
 
Fig. (1). Chest CT (axial slice) of a 64 year-old male patient.All lung parenchyma with an attenuation value of less than -910 HU is 
highlighted in green (left image) using image segmentation software. The volume of the region of interest (green areas) is then calculated. 
The corresponding slice is shown on the right prior to application of our technique. 
/  
CT Densitometry as a Predictor of Pulmonary Function The Open Respiratory Medicine Journal, 2012, Volume 6    141 
 FEV1 (% of predicted) correlated significantly with the 
volume of emphysema (values less than -910 HU) (r= -.678, 
p<0.001) (see Fig. 2) and the mean lung density (r=.762, 
p<0.001) (see Fig. 3). DLCO (% of predicted) correlated with 
the mean lung density (r =.648, p<0.001) (see Fig. 4) and the 
volume of emphysema (r= -.535, p<0.001) (see Fig. 5). 
 Table 1 shows the strengh of association of the CT 
measures with other pulmonary function indices (see Table 
1). 
DISCUSSION 
 Lung cancer is the leading cause of cancer death in the 
United States. Surgical resection is the treatment of choice 
for patients with localised non-small cell carcinoma. The 
incidence of complications varies, depending on the extent 
of the resection, the pulmonary reserve of the patient, and the 
presence of comorbid factors. 
 
Fig. (2). Correlation between forced expiratory volume in the first second (FEV1 - % of predicted) and the volume of emphysema (cm
3
) (r= -
.678, p<0.001). 
Fig. (3). Correlation between the forced expiratory volume in the first second (FEV1 -% of predicted) and the mean lung density (HU). (r= 
.762; p <0.001). 
r= ‐.678, p<0.001 
r= .762, p<0.001 
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 Preoperative risk-stratification of potential candidates is 
essential prior to surgery. Pulmonary assessment is 
especially important as patients with lung cancer are more 
likely to be smokers and have airways disease. 
 Emphysema is characterised by destruction of the 
airways distal to the terminal bronchioles as evident by areas 
of abnormally low attenuation on CT. A lung attenuation 
threshold of -910 HU was chosen to differentiate low 
attenuation areas of emphysema from normal lung 
parenchyma after a review of the literature. Several 
attenuation thresholds have been quoted by different studies 
for the recogniton of emphysematous lung ranging from -910 
to -950 HU [6-10]. Muller et al found good correlation with 
macroscopic emphysema using an attenuation threshold of -
910 HU in patients who had received intravenous contrast 
[9]. All of the patients in our study received intravenous 
contrast prior to image acquisition. Although contrast 
medium increases the attenuation of lung parenchyma, we 
choose an attenuation threshold that had been found by 
previous studies to correlate well with emphysema on CT in 
patients who had received intravenous contrast as part of 
their scan protocal. Moreover, other studies that omit 
intravenous contrast from the scan protocal report similar 
attenuation thresholds in the range of -900 to -910 to 
segment emphsematous lung [7]. 
 
Fig. (4). Correlation between diffusion capacity for carbon monoxide (DLCO -% of predicted) and the mean lung density (r=.648; p<0.001). 
 
Fig. (5). Correlation between diffusion capacity for carbon monoxide (DLCO -% of predicted) and the volume of emphysema (cm
3
) (r=-
.535; p<0.001). 
r= .648, p<0.001
r= ‐.535, p<0.001 
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 We choose to omit patients with a history of 
pneumonectomy, lobectomy, and pleural effusion on CT as 
this would lead to erronous measures of lung volume. 
Furthermore, patients with CT signs of pulmonary fibrosis 
were excluded due to the volume reducing effect of 
restrictive lung disease. 
 Our findings are in keeping with previous studies that 
report significant correlation between areas of lung with low 
attenuation and spirometric measures of pulmonary function. 
As observed by several studies, both FEV1 and DLCO were 
found to correlate significantly with the volume of 
emphysema [8, 9, 11-15].
 
 Moreover, DLCO was found to correlate with mean lung 
density in this study. Failure of FEV1 and DLCO to correlate 
with total lung volume may be due to the fact that we lacked 
normal reference values of lung volume in size-matched 
controls. However, exposing healthy individuals to radiation 
for this purpose is unjustified. 
 We now plan to prospectively compare these CT 
parameters with measures of good and poor outcome 
postoperatively in patients undergoing lung surgery. This 
may allow us to accurately determine CT measurements that 
could be used as a predictor of surgical outcome 
preoperatively and identify patients who would tolerate 
surgical resection. We are not proposing that CT replaces 
pulmonary function testing but both modalities are 
potentially complimentary. In time, with improvements in 
CT densitometry, CT may obviate the need for pulmonary 
function testing in selected patients, resulting in reduced 
healthcare costs and delays prior to surgery. It must be 
stressed that these measures of lung volume and density are 
obtained from clinically indicated pre-operative staging CT 
scans in patients with lung cancer and do not require any 
modification of imaging protocol, additional exposure to 
ionising radiation or additional scanning time. 
 We recognise the limitations of our study. Our cohort 
consisted largely of patients with mild to moderate 
emphysema. Thus our results may not be applicable to 
patients with severe disease. We plan to further study the use 
of these techniques in this clinical setting, in a prospective 
trial with larger numbers of lung cancer patients to determine 
if our results retain their validity. Although image aquisiition 
was performed during breath-hold at the end of inspiration, it 
is possible that some of the patients did not or were unable to 
comply which would alter measures of lung volume and 
density. Although patients with features of fibrosis on CT 
were excluded, patients with early subtle changes or 
spirometric evidence of fibrotic lung disease may have 
inadvertently been included. Furthermore, it is likely that our 
correlations would not hold true for patients who also have 
co-exisitng fibrotic lung disease. 
 It is also worth noting that the strength of assocation 
observed between the CT measures and DLCO/VA were not 
as strong as those obseved with DLCO. The explanation for 
this is a unclear. 
 In conclusion, the results of this study suggest that both 
FEV1 and DLCO correlate significantly with volume of 
emphysema and mean lung density. We now plan to 
prospectively compare these CT parameters with measures 
of good and poor outcome postoperatively to identify CT 
measures that may predict surgical outcome preoperatively. 
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